# TG4040 in Patients With Chronic HCV

> **NCT00449124** · PHASE1 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Placebo
- **BIOLOGICAL:** TG4040

## Key facts

- **NCT ID:** NCT00449124
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00449124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00449124, "TG4040 in Patients With Chronic HCV". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00449124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*